(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 5.34% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.87%.
Rockwell Medical's revenue in 2024 is $83,612,000.On average, 1 Wall Street analysts forecast RMTI's revenue for 2024 to be $2,583,793,065, with the lowest RMTI revenue forecast at $2,583,793,065, and the highest RMTI revenue forecast at $2,583,793,065.
In 2025, RMTI is forecast to generate $3,051,973,553 in revenue, with the lowest revenue forecast at $3,051,973,553 and the highest revenue forecast at $3,051,973,553.